LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Real Estate & Property Management Companies for Sale
Farms & Vineyards for Sale
Digital Marketing Business for Sale
Service Businesses for Sale
Retail Businesses for Sale
Warehouse & Storage Businesses for Sale
Construction & Landscaping Businesses for Sale
Advertising & Promotional Businesses for Sale
Startup Investment Opportunities
Finance & Accounting Businesses for Sale
Post Office Franchises for Sale
Consultancy & Training Franchise Opportunities
Coffee, Bakery & Dessert Franchise Opportunities
Home Based Franchise Opportunities
Fitness & Wellness Franchises for Sale
Finance & Accounting Franchise Opportunities
Transport & Shipping Franchise Opportunities
Healthcare & Medical Franchise Opportunities
Technology Franchise Opportunities
Clothing & Shoe Store Franchise Opportunities
Medical Office Spaces for Sale or Rent
Commercial Buildings for Sale or Lease
Plazas for Sale
Retail Buildings for Sale or Lease
Retail Spaces for Lease or Sale
Office Spaces for Sale or Rent
Houses & Condos for Sale or Lease
Industrial Buildings for Sale or Lease
Land & Developments for Sale
Office Buildings for Sale or Rent
An email will be sent to registered email address.
Please select if you are: